Article

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaques

2021-09-29

Abstract excerpt

<h4>ABSTRACT</h4> Human monoclonal antibody (mAb) treatments are promising for COVID-19 prevention, post-exposure prophylaxis, or therapy. However, the titer of neutralizing antibodies required for protection against SARS-CoV-2 infection remains poorly characterized. We previously described two potently neutralizing mAbs COV2-2130 and COV2-2381 targeting non-overlapping epitopes on the receptor-binding domain of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 29b0ad00-bf8c-5b42-b65f-420941f62a8b
DOI: 10.1101/2021.09.27.462074

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaquesDOI 10.1101/2021.09.27.462074Read

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccinationSemantic proximity Read

Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesSemantic proximity Read

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsSemantic proximity Read

SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibodySemantic proximity Read

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelSemantic proximity Read

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants.Semantic proximity Read

Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Semantic proximity Read

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccinationSemantic proximity Read

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionSemantic proximity Read

Fc-engineered antibody therapeutics with improved efficacy against COVID-19Semantic proximity Read

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesSemantic proximity Read

A Novel Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2Semantic proximity Read